Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting. [electronic resource]
Producer: 20100106Description: 849-56 p. digitalISSN:- 1552-4469
- Anti-Bacterial Agents -- pharmacology
- Cell Division -- drug effects
- Chromatography, Liquid -- methods
- Cycloserine -- pharmacology
- Doxorubicin -- pharmacology
- Drug Resistance, Multiple -- genetics
- Escherichia coli -- drug effects
- Escherichia coli Proteins -- drug effects
- Fosfomycin -- analogs & derivatives
- Genes, Bacterial -- drug effects
- Genome, Bacterial -- genetics
- Genomics -- methods
- Lipoproteins -- antagonists & inhibitors
- Mass Spectrometry -- methods
- Molecular Chaperones -- antagonists & inhibitors
- Periplasmic Binding Proteins -- drug effects
- Pseudomonas aeruginosa -- drug effects
- Sulfamethoxazole -- pharmacology
- Suppression, Genetic
- Trimethoprim -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.